Charlemagne Capital as of March 31, 2014
Portfolio Holdings for Charlemagne Capital
Charlemagne Capital holds 53 positions in its portfolio as reported in the March 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Banco Itau Holding Financeira (ITUB) | 15.2 | $20M | 1.4M | 14.87 | |
Baidu (BIDU) | 13.1 | $17M | 114k | 151.98 | |
Vale (VALE) | 9.3 | $12M | 895k | 13.83 | |
Fomento Economico Mexicano SAB (FMX) | 7.4 | $9.8M | 105k | 93.12 | |
Ambev Sa- (ABEV) | 7.2 | $9.5M | 1.3M | 7.41 | |
Petroleo Brasileiro SA (PBR.A) | 6.3 | $8.4M | 604k | 13.84 | |
CTC Media | 6.0 | $7.9M | 856k | 9.22 | |
New Oriental Education & Tech | 5.9 | $7.9M | 268k | 29.38 | |
Compania Cervecerias Unidas (CCU) | 5.6 | $7.4M | 330k | 22.35 | |
Banco Bradesco SA (BBD) | 3.8 | $5.0M | 367k | 13.68 | |
Grupo Televisa (TV) | 3.7 | $4.9M | 146k | 33.31 | |
Credicorp (BAP) | 3.3 | $4.4M | 32k | 137.34 | |
Copa Holdings Sa-class A (CPA) | 2.8 | $3.7M | 20k | 183.80 | |
BRF Brasil Foods SA (BRFS) | 2.5 | $3.4M | 170k | 19.94 | |
Grana Y Montero S A A | 2.0 | $2.6M | 151k | 17.28 | |
Avianca Holdings Sa | 1.3 | $1.7M | 101k | 16.96 | |
Johnson & Johnson (JNJ) | 0.5 | $602k | 6.1k | 98.29 | |
Pfizer (PFE) | 0.5 | $596k | 19k | 32.12 | |
Petroleo Brasileiro SA (PBR) | 0.4 | $485k | 37k | 13.14 | |
Merck & Co (MRK) | 0.3 | $378k | 6.6k | 56.85 | |
Gerdau SA (GGB) | 0.3 | $370k | 58k | 6.43 | |
Cosan Ltd shs a | 0.2 | $260k | 23k | 11.41 | |
Allergan | 0.2 | $234k | 1.9k | 123.74 | |
Insulet Corporation (PODD) | 0.2 | $231k | 4.9k | 47.45 | |
Bristol Myers Squibb (BMY) | 0.1 | $198k | 3.8k | 51.81 | |
Abbvie (ABBV) | 0.1 | $204k | 4.0k | 51.46 | |
Orexigen Therapeutics | 0.1 | $182k | 28k | 6.43 | |
Medtronic | 0.1 | $167k | 2.7k | 61.44 | |
Mylan | 0.1 | $170k | 3.5k | 48.78 | |
Gilead Sciences (GILD) | 0.1 | $177k | 2.5k | 70.74 | |
Thermo Fisher Scientific (TMO) | 0.1 | $155k | 1.3k | 120.53 | |
Sanofi-Aventis SA (SNY) | 0.1 | $142k | 2.7k | 52.59 | |
Theravance | 0.1 | $140k | 4.4k | 32.17 | |
Illumina (ILMN) | 0.1 | $142k | 952.00 | 149.16 | |
Medivation | 0.1 | $148k | 2.3k | 64.52 | |
Amgen (AMGN) | 0.1 | $131k | 1.1k | 123.00 | |
Forest Laboratories | 0.1 | $117k | 1.3k | 92.20 | |
Salix Pharmaceuticals | 0.1 | $110k | 1.1k | 103.00 | |
Abbott Laboratories (ABT) | 0.1 | $75k | 1.9k | 38.66 | |
Becton, Dickinson and (BDX) | 0.1 | $82k | 697.00 | 117.65 | |
Nanostring Technologies (NSTGQ) | 0.1 | $85k | 4.1k | 20.83 | |
Regeneron Pharmaceuticals (REGN) | 0.1 | $70k | 233.00 | 300.43 | |
Biogen Idec (BIIB) | 0.1 | $72k | 236.00 | 305.08 | |
Celgene Corporation | 0.0 | $49k | 348.00 | 140.80 | |
Covance | 0.0 | $50k | 842.00 | 59.38 | |
NPS Pharmaceuticals | 0.0 | $56k | 1.9k | 29.85 | |
Pharmacyclics | 0.0 | $52k | 519.00 | 100.19 | |
Arrowhead Research | 0.0 | $54k | 3.3k | 16.34 | |
Quintiles Transnatio Hldgs I | 0.0 | $49k | 973.00 | 50.36 | |
Baxter International (BAX) | 0.0 | $37k | 499.00 | 74.15 | |
Waters Corporation (WAT) | 0.0 | $34k | 315.00 | 107.94 | |
Cubist Pharmaceuticals | 0.0 | $45k | 612.00 | 73.53 | |
Medicines Company | 0.0 | $27k | 970.00 | 27.84 |